Literature DB >> 1749226

The place of fetal liver transplantation in the treatment of inborn errors of metabolism.

J L Touraine1, S Laplace, F Rezzoug, K Sanhadji, P Veyron, C Royo, I Maire, M T Zabot, M T Vanier, M O Rolland.   

Abstract

Over the last 16 years, 202 fetal tissue transplants have been performed in our department to treat 29 patients with severe inborn errors of metabolism without immunodeficiency, 26 patients with congenital and severe immunodeficiency diseases, and 2 patients with severe aplastic anaemia. The actuarial survival curve of patients with inborn errors of metabolism treated with fetal liver transplantation shows a 12-year survival of 77%. The condition of many of these patients has been improved by the treatment, but transplantation has had to be repeated in order to maintain clinical amelioration. Enzyme levels were not significantly and durably increased in peripheral blood but the quantities of substrates detected in sera and urines were significantly reduced and tissue deposits were stabilized.

Entities:  

Mesh:

Year:  1991        PMID: 1749226     DOI: 10.1007/bf01797931

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  Fetal liver cell transplantation: survival of grafted BALB/c lysosomal storage disease mice.

Authors:  P Veyron; J L Touraine
Journal:  Transplant Proc       Date:  1990-10       Impact factor: 1.066

2.  New strategies in the treatment of immunological and other inherited diseases: allogeneic stem cells transplantation.

Authors:  J L Touraine
Journal:  Bone Marrow Transplant       Date:  1989-12       Impact factor: 5.483

3.  In-utero transplantation of stem cells in bare lymphocyte syndrome.

Authors:  J L Touraine; D Raudrant; C Royo; A Rebaud; M G Roncarolo; G Souillet; N Philippe; F Touraine; H Bétuel
Journal:  Lancet       Date:  1989-06-17       Impact factor: 79.321

4.  Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.

Authors:  R O Brady; J F Tallman; W G Johnson; A E Gal; W R Leahy; J M Quirk; A S Dekaban
Journal:  N Engl J Med       Date:  1973-07-05       Impact factor: 91.245

5.  Bone marrow transplantation for inborn errors.

Authors:  J R Hobbs
Journal:  Lancet       Date:  1981-10-03       Impact factor: 79.321

6.  [Renal transplantation in patients suffering from Fabry's disease. Kidney transplantation from an heterozygote subject to a subject without Fabry's disease].

Authors:  J P Grünfeld; M Le Porrier; D Droz; I Bensaude; N Hinglais; J Crosnier
Journal:  Nouv Presse Med       Date:  1975-09-13

Review 7.  Bone-marrow and fetal-liver transplantation in immunodeficiencies and inborn errors of metabolism: lack of significant restriction of T-cell function in long-term chimeras despite HLA-mismatch.

Authors:  J L Touraine
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

8.  Fetal tissue transplantation, bone marrow transplantation and prospective gene therapy in severe immunodeficiencies and enzyme deficiencies.

Authors:  J L Touraine; M G Roncarolo; C Royo; F Touraine
Journal:  Thymus       Date:  1987

9.  Cooperation between major histocompatibility complex mismatched mononuclear cells from a human chimera in the production of antigen-specific antibody.

Authors:  M G Roncarolo; J L Touraine; J Banchereau
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

  9 in total
  1 in total

1.  Orthotopic liver transplantation in liver-based metabolic disorders.

Authors:  A P Mowat
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.